• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫细胞因子介导体细胞凋亡的聚合机械放大器。

Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis.

机构信息

Department of Chemical Engineering, David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts 02139, USA.

出版信息

Nat Commun. 2017 Mar 20;8:14179. doi: 10.1038/ncomms14179.

DOI:10.1038/ncomms14179
PMID:28317839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5364380/
Abstract

Physical forces affect tumour growth, progression and metastasis. Here, we develop polymeric mechanical amplifiers that exploit in vitro and in vivo physical forces to increase immune cytokine-mediated tumour cell apoptosis. Mechanical amplifiers, consisting of biodegradable polymeric particles tethered to the tumour cell surface via polyethylene glycol linkers, increase the apoptotic effect of an immune cytokine on tumour cells under fluid shear exposure by as much as 50% compared with treatment under static conditions. We show that targeted polymeric particles delivered to tumour cells in vivo amplify the apoptotic effect of a subsequent treatment of immune cytokine, reduce circulating tumour cells in blood and overall tumour cell burden by over 90% and reduce solid tumour growth in combination with the antioxidant resveratrol. The work introduces a potentially new application for a broad range of micro- and nanoparticles to maximize receptor-mediated signalling and function in the presence of physical forces.

摘要

物理力会影响肿瘤的生长、进展和转移。在这里,我们开发了聚合物机械增敏剂,利用体外和体内的物理力来增加免疫细胞因子介导的肿瘤细胞凋亡。机械增敏剂由通过聚乙二醇接头连接到肿瘤细胞表面的可生物降解聚合物颗粒组成,与静态条件下的治疗相比,在流体剪切暴露下,免疫细胞因子对肿瘤细胞的凋亡作用增加了多达 50%。我们表明,体内递送到肿瘤细胞的靶向聚合物颗粒可增强随后免疫细胞因子治疗的凋亡作用,将血液中的循环肿瘤细胞和总肿瘤细胞负担减少 90%以上,并与抗氧化剂白藜芦醇联合减少实体瘤生长。这项工作为广泛的微纳米颗粒引入了一种潜在的新应用,以在存在物理力的情况下最大化受体介导的信号转导和功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/5404c07d0221/ncomms14179-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/c697932a1555/ncomms14179-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/90e50fddafde/ncomms14179-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/35defc5c3f0f/ncomms14179-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/035de380d69a/ncomms14179-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/23ef650e6620/ncomms14179-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/5404c07d0221/ncomms14179-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/c697932a1555/ncomms14179-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/90e50fddafde/ncomms14179-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/35defc5c3f0f/ncomms14179-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/035de380d69a/ncomms14179-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/23ef650e6620/ncomms14179-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba4/5364380/5404c07d0221/ncomms14179-f6.jpg

相似文献

1
Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis.免疫细胞因子介导体细胞凋亡的聚合机械放大器。
Nat Commun. 2017 Mar 20;8:14179. doi: 10.1038/ncomms14179.
2
The roadmap of TRAIL apoptotic pathway-targeted cancer therapies: What is next?靶向TRAIL凋亡途径的癌症治疗路线图:下一步是什么?
Expert Rev Anticancer Ther. 2012 May;12(5):547-9. doi: 10.1586/era.12.33.
3
Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.新型非甾体抗炎药CG100649对结肠癌的预防和治疗活性评估:肿瘤坏死因子相关凋亡诱导配体受体表达增加增强了对TRAIL联合治疗的凋亡反应。
Oncol Rep. 2015 Apr;33(4):1947-55. doi: 10.3892/or.2015.3793. Epub 2015 Feb 10.
4
Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.新型促凋亡药物NCL - 240、肿瘤坏死因子相关凋亡诱导配体(TRAIL)与小干扰RNA(siRNA)的联合纳米制剂
Pharm Res. 2016 Jul;33(7):1587-601. doi: 10.1007/s11095-016-1899-z. Epub 2016 Mar 7.
5
A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.一种新型的可溶性化合物C25通过上调DR5表达使细胞对TRAIL诱导的凋亡敏感。
Anticancer Drugs. 2015 Jun;26(5):518-30. doi: 10.1097/CAD.0000000000000213.
6
Bortezomib and TRAIL: a perfect match for apoptotic elimination of tumour cells?硼替佐米联合 TRAIL:诱导肿瘤细胞凋亡的完美组合?
Crit Rev Oncol Hematol. 2013 Mar;85(3):363-72. doi: 10.1016/j.critrevonc.2012.08.001. Epub 2012 Sep 1.
7
TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.TNF 相关凋亡诱导配体通过激活 Wnt 信号通路与 NSAIDs 在(前)恶性结肠细胞中协同作用。
J Pathol. 2011 Feb;223(3):378-89. doi: 10.1002/path.2797. Epub 2010 Oct 29.
8
Synergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micelles.阳离子聚合物胶束共递送 TRAIL 和紫杉醇实现协同抗癌作用。
Macromol Biosci. 2011 Feb 11;11(2):296-307. doi: 10.1002/mabi.201000332. Epub 2010 Dec 8.
9
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib.sTRAIL 与脂质体偶联可改善其药代动力学特性,并与硼替佐米联合克服神经母细胞瘤肿瘤耐药性。
J Control Release. 2014 Oct 28;192:157-66. doi: 10.1016/j.jconrel.2014.07.009. Epub 2014 Jul 17.
10
TRAIL receptor signalling and modulation: Are we on the right TRAIL?肿瘤坏死因子相关凋亡诱导配体(TRAIL)受体信号传导与调节:我们是否选对了TRAIL?
Cancer Treat Rev. 2009 May;35(3):280-8. doi: 10.1016/j.ctrv.2008.11.006. Epub 2008 Dec 30.

引用本文的文献

1
Light-triggered molecular mechanotherapy of tumor using membrane-mimicking conjugated oligoelectrolytes.使用模拟细胞膜的共轭寡电解质进行肿瘤的光触发分子机械疗法
Sci Adv. 2025 Aug 22;11(34):eady3349. doi: 10.1126/sciadv.ady3349.
2
Acoustic technologies for the orchestration of cellular functions for therapeutic applications.用于编排细胞功能以实现治疗应用的声学技术。
Sci Adv. 2025 Jul 18;11(29):eadu4759. doi: 10.1126/sciadv.adu4759.
3
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.纳米技术在恶性肿瘤诊断与治疗中的最新进展。

本文引用的文献

1
Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities.肿瘤坏死因子相关凋亡诱导配体(TRAIL)三聚体的异质修饰以改善药物递送和体内抗肿瘤活性。
Sci Rep. 2015 Oct 8;5:14872. doi: 10.1038/srep14872.
2
Piperlongumine and immune cytokine TRAIL synergize to promote tumor death.胡椒碱与免疫细胞因子TRAIL协同作用促进肿瘤细胞死亡。
Sci Rep. 2015 May 18;5:9987. doi: 10.1038/srep09987.
3
Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies.
Signal Transduct Target Ther. 2024 Aug 12;9(1):200. doi: 10.1038/s41392-024-01889-y.
4
Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression.肿瘤微环境中可离子化脂质纳米颗粒介导的 TRAIL mRNA 递送抑制结肠癌细胞进展。
Int J Nanomedicine. 2024 Mar 14;19:2655-2673. doi: 10.2147/IJN.S452896. eCollection 2024.
5
Lipid Phase Separation in Vesicles Enhances TRAIL-Mediated Cytotoxicity.脂质相分离增强 TRAIL 介导的细胞毒性。
Nano Lett. 2022 Apr 13;22(7):2627-2634. doi: 10.1021/acs.nanolett.1c04365. Epub 2022 Mar 17.
6
Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy.工程细胞因子在癌症和自身免疫性疾病免疫治疗中的应用。
Adv Healthc Mater. 2021 Aug;10(15):e2002214. doi: 10.1002/adhm.202002214. Epub 2021 Mar 9.
7
TRAIL of Hope Meeting Resistance in Cancer.希望之路在癌症治疗中遭遇阻力。
Trends Cancer. 2020 Dec;6(12):989-1001. doi: 10.1016/j.trecan.2020.06.006. Epub 2020 Jul 24.
8
Drug-free albumin-triggered sensitization of cancer cells to anticancer drugs.无药物白蛋白触发癌细胞对抗癌药物的敏感性。
J Control Release. 2019 Jan 10;293:84-93. doi: 10.1016/j.jconrel.2018.11.015. Epub 2018 Nov 19.
9
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.化疗诱导的细胞凋亡、自噬和细胞周期停滞是上皮性卵巢癌化疗免疫治疗协同作用的关键驱动因素。
Cancer Immunol Immunother. 2018 Nov;67(11):1753-1765. doi: 10.1007/s00262-018-2199-8. Epub 2018 Aug 24.
10
Regimes of Flow over Complex Structures of Endothelial Glycocalyx: A Molecular Dynamics Simulation Study.复杂内皮糖萼结构的流动模式:分子动力学模拟研究。
Sci Rep. 2018 Apr 10;8(1):5732. doi: 10.1038/s41598-018-24041-7.
固定化表面活性剂-纳米管复合物在没有捕获抗体的情况下支持选择素介导的活循环肿瘤细胞捕获。
J Biomed Mater Res A. 2015 Oct;103(10):3407-18. doi: 10.1002/jbm.a.35445. Epub 2015 Mar 30.
4
Cooperative effects of matrix stiffness and fluid shear stress on endothelial cell behavior.基质硬度与流体剪切应力对内皮细胞行为的协同作用。
Biophys J. 2015 Feb 3;108(3):471-8. doi: 10.1016/j.bpj.2014.12.023.
5
Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions.靶向癌症中的外源性凋亡途径:经验教训与未来方向。
J Clin Invest. 2015 Feb;125(2):487-9. doi: 10.1172/JCI80420. Epub 2015 Feb 2.
6
Human serum albumin-TRAIL conjugate for the treatment of rheumatoid arthritis.用于治疗类风湿性关节炎的人血清白蛋白-肿瘤坏死因子相关凋亡诱导配体缀合物
Bioconjug Chem. 2014 Dec 17;25(12):2212-21. doi: 10.1021/bc500427g. Epub 2014 Nov 20.
7
Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors.流体剪切应力通过三聚体死亡受体使癌细胞对受体介导的凋亡敏感。
New J Phys. 2013 Jan 18;15:015008. doi: 10.1088/1367-2630/15/1/015008.
8
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib.sTRAIL 与脂质体偶联可改善其药代动力学特性,并与硼替佐米联合克服神经母细胞瘤肿瘤耐药性。
J Control Release. 2014 Oct 28;192:157-66. doi: 10.1016/j.jconrel.2014.07.009. Epub 2014 Jul 17.
9
Fluid shear stress increases neutrophil activation via platelet-activating factor.流体切应力通过血小板激活因子增加中性粒细胞的激活。
Biophys J. 2014 May 20;106(10):2243-53. doi: 10.1016/j.bpj.2014.04.001.
10
TRAIL-coated leukocytes that kill cancer cells in the circulation.载有 TRAIL 的白细胞能在血液中杀死癌细胞。
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):930-5. doi: 10.1073/pnas.1316312111. Epub 2014 Jan 6.